Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
BioXcel Therapeutics, Inc. | Director, 10%+ Owner | Common Stock | 8.55M | $187M | $21.89 | Apr 6, 2023 | Indirect |
BioXcel Therapeutics, Inc. | Director, 10%+ Owner | Stock Options | 294K | Apr 6, 2023 | Direct | ||
BioXcel Therapeutics, Inc. | Director, 10%+ Owner | Common Stock | 0 | $21.89 | Apr 6, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
BTAI | BioXcel Therapeutics, Inc. | Apr 6, 2023 | 3 | -$1.01M | 4 | Apr 10, 2023 | Director, 10%+ Owner |
BTAI | BioXcel Therapeutics, Inc. | Jan 4, 2023 | 8 | -$1.3M | 4 | Jan 6, 2023 | Director, 10%+ Owner |
BTAI | BioXcel Therapeutics, Inc. | Dec 31, 2022 | 3 | $0 | 5 | Feb 14, 2023 | Director |
BTAI | BioXcel Therapeutics, Inc. | Nov 10, 2022 | 6 | -$875K | 4 | Nov 14, 2022 | Director, 10%+ Owner |
BTAI | BioXcel Therapeutics, Inc. | Dec 31, 2021 | 4 | $0 | 5 | Feb 14, 2022 | Director |
BTAI | BioXcel Therapeutics, Inc. | Jun 25, 2021 | 1 | -$14.6M | 4 | Jun 29, 2021 | Director |